Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort

Objective Although cancer promotes inflammation, the role of inflammation in tumor-genesis is less well established. The aim was to examine if low-grade inflammation is related to post-menopausal breast cancer risk, and if obesity modifies this association. Methods In the Malmö Diet and Cancer cohort, a nested case-control study was defined among 8,513 women free of cancer and aged 55–73 years at baseline (1991–96); 459 were diagnosed with invasive breast cancer during follow-up (until December 31st, 2010). In laboratory analyses of blood from 446 cases, and 885 controls (matched on age and date of blood sampling) we examined systemic inflammation markers: oxidized (ox)-LDL, interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor (TNF)-α, white blood cells, lymphocytes and neutrophils. Odds ratios (OR) and 95% confidence intervals (CI) for breast cancer risk was calculated using multivariable conditional logistic regression. Results Inverse associations with breast cancer were seen in fully-adjusted models, for 2nd and 3rd tertiles of ox-LDL, OR (95% CI): 0.65 (0.47–0.90), 0.63 (0.45–0.89) respectively, p-trend = 0.01; and for the 3rd tertile of TNF-α, 0.65 (0.43–0.99), p-trend = 0.04. In contrast, those in the highest IL-1β category had higher risk, 1.71 (1.05–2.79), p-trend = 0.01. Obesity did not modify associations between inflammation biomarkers and breast cancer. Conclusion Our study does not suggest that low-grade inflammation increase the risk of post-menopausal breast cancer.

[1]  B. Hedblad,et al.  Plasma variation and reproducibility of oxidized LDL-cholesterol and low-grade inflammation biomarkers among participants of the Malmö Diet and Cancer cohort , 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[2]  S. Rubin,et al.  Chronic inflammation and risk of colorectal and other obesity‐related cancers: The health, aging and body composition study , 2016, International journal of cancer.

[3]  D. Leroith,et al.  Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms. , 2015, Handbook of experimental pharmacology.

[4]  H. Ni,et al.  Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies , 2015, PloS one.

[5]  J. Roth,et al.  The transcription factor nuclear factor interleukin 6 mediates pro- and anti-inflammatory responses during LPS-induced systemic inflammation in mice , 2015, Brain, Behavior, and Immunity.

[6]  D. Greenwood,et al.  Circulating C-Reactive Protein and Breast Cancer Risk—Systematic Literature Review and Meta-analysis of Prospective Cohort Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[7]  M. Touvier,et al.  Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies , 2015, British Journal of Nutrition.

[8]  I. McInnes,et al.  Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases , 2015, Pharmacological Reviews.

[9]  D. Khismatullin,et al.  Oxidized Low-Density Lipoprotein Contributes to Atherogenesis via Co-activation of Macrophages and Mast Cells , 2015, PloS one.

[10]  S. Mousa,et al.  Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases , 2015, Critical reviews in clinical laboratory sciences.

[11]  J. Morales-Montor,et al.  The role of cytokines in breast cancer development and progression. , 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[12]  T. Mukherjee,et al.  Mechanistic insight of drug resistance with special focus on iron in estrogen receptor positive breast cancer. , 2014, Current pharmaceutical biotechnology.

[13]  C. Madeddu,et al.  Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer , 2014, Journal of cellular and molecular medicine.

[14]  M. Paesmans,et al.  Systematic review about breast cancer incidence in relation to hormone replacement therapy use , 2014, Climacteric : the journal of the International Menopause Society.

[15]  I. Romieu,et al.  Female breast cancer and alcohol consumption: a review of the literature. , 2014, American journal of preventive medicine.

[16]  Bhanu P. Jena,et al.  Journal of Cellular and Molecular Medicine , 2014, Journal of Cellular and Molecular Medicine.

[17]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[18]  B. Hedblad,et al.  Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[19]  S. Sinha,et al.  Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. , 2013, Cytokine & growth factor reviews.

[20]  E. Simpson,et al.  Obesity and breast cancer: role of inflammation and aromatase. , 2013, Journal of molecular endocrinology.

[21]  S. Su,et al.  A critical role for interleukin-1β in the progression of autoimmune diseases. , 2013, International immunopharmacology.

[22]  D. Rose,et al.  The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer , 2013, Journal of Mammary Gland Biology and Neoplasia.

[23]  Gemma A. Figtree,et al.  Biological markers of oxidative stress: Applications to cardiovascular research and practice☆ , 2013, Redox biology.

[24]  J. Chae,et al.  Effect of age on atherogenicity of LDL and inflammatory markers in healthy women. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[25]  C. Hudis,et al.  Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer , 2013, Clinical Cancer Research.

[26]  M. Dowsett,et al.  Sex hormones and breast cancer risk and prognosis. , 2013, Breast.

[27]  P. Hojman,et al.  The role of intratumoral and systemic IL-6 in breast cancer , 2013, Breast Cancer Research and Treatment.

[28]  E. Simpson,et al.  Minireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolism. , 2013, Molecular endocrinology.

[29]  J. Slingerland,et al.  Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. , 2013, Annual review of medicine.

[30]  J. Stevens,et al.  The Atherosclerosis Risk in Communities Study , 2013 .

[31]  J. Carvalho,et al.  Molecular link mechanisms between inflammation and cancer. , 2012, Current pharmaceutical design.

[32]  O. Melander,et al.  Incidence of Coronary Events and Case Fatality Rate in Relation to Blood Lymphocyte and Neutrophil Counts , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[33]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[34]  S. Hulley The US National Cholesterol Education Program , 2012, Drugs.

[35]  N. Rothman,et al.  Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. , 2011, Cytokine.

[36]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[37]  T. Meshel,et al.  Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition , 2011, BMC Cancer.

[38]  D Goldberg,et al.  Critical Reviews in Clinical Laboratory Sciences , 2010, Critical reviews in clinical laboratory sciences.

[39]  M. Karin,et al.  Inflammation and oncogenesis: a vicious connection. , 2010, Current opinion in genetics & development.

[40]  Wei Liu,et al.  Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy , 2009, Carcinogenesis.

[41]  G. Berglund,et al.  Ability of physical activity measurements to assess health-related risks , 2009, European Journal of Clinical Nutrition.

[42]  P. Allavena,et al.  Cellular and molecular pathways linking inflammation and cancer. , 2009, Immunobiology.

[43]  T. Stulnig,et al.  Obesity, Inflammation, and Insulin Resistance – A Mini-Review , 2009, Gerontology.

[44]  G. Z. Rocha,et al.  Epidemiological and molecular mechanisms aspects linking obesity and cancer. , 2009, Arquivos brasileiros de endocrinologia e metabologia.

[45]  K. Jirström,et al.  Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer , 2009, International journal of cancer.

[46]  Alberto Mantovani,et al.  Cytokines as a key component of cancer-related inflammation. , 2008, Cytokine.

[47]  P. Allavena,et al.  Pathways connecting inflammation and cancer. , 2008, Current opinion in genetics & development.

[48]  E. Stathopoulou,et al.  Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. , 2007, Clinical biochemistry.

[49]  W. Willett,et al.  Adult height, age at attained height, and incidence of breast cancer in premenopausal women , 2006, International journal of cancer.

[50]  A. Nicolini,et al.  Cytokines in breast cancer. , 2006, Cytokine & growth factor reviews.

[51]  Juan Tang,et al.  TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells. , 2005, Biochemical and biophysical research communications.

[52]  Imran Awan,et al.  Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.

[53]  A. Tamakoshi,et al.  Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  Graham A Colditz,et al.  Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.

[55]  R. Krajcik,et al.  No Association between Serum Levels of Tumor Necrosis Factor-α (TNF-α) or the Soluble Receptors sTNFR1 and sTNFR2 and Breast Cancer Risk , 2003 .

[56]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[57]  G. Berglund,et al.  Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[58]  P. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[59]  G. Berglund,et al.  A prospective study of adiposity and postmenopausal breast cancer risk: The Malmö diet and cancer study , 2003, International journal of cancer.

[60]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[61]  M. Lindholm,et al.  Inflammation and cholesterol , 2002 .

[62]  A. Purohit,et al.  The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer , 2002, Breast Cancer Research.

[63]  G. Berglund,et al.  The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non‐participants , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[64]  G. Berglund,et al.  Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. , 2000, American journal of epidemiology.

[65]  C. Woodworth,et al.  Tumor necrosis factor‐α promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin‐dependent kinase activity in HPV‐immortalized keratinocytes by a ras‐dependent pathway , 2000, Molecular carcinogenesis.

[66]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[67]  W. Erl,et al.  Effects of Oxidized Low Density Lipoprotein, Lipid Mediators and Statins on Vascular Cell Interactions , 1999, Clinical chemistry and laboratory medicine.

[68]  F. Werf,et al.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.

[69]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[70]  B E Ainsworth,et al.  Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. , 1994, Journal of clinical epidemiology.

[71]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[72]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.